Document is current
Any future updates will be listed below
-
Authors
Planinc, Ivo
Garcia-Canadilla, Patricia
Dejea, Hector
Ilic, Ivana
Guasch, Eduard
Zamora, Monica
Crispi, Fàtima
Stampanoni, Marco
Milicic, Davor
Bijnens, Bart
Bonnin, Anne
Cikes, Maja
- License Information
-
More Information
Article History
Received: 26 January 2021
Accepted: 16 June 2021
First Online: 7 July 2021
Competing interest
: I.P. reports grants, personal fees and non-financial support from consulting honoraria, speaker fees and educational grants from Novartis, Pfizer, Boehringer-Ingelheim, Teva Pharmaceutical Industries, Bayer, Krka, Servier, Sandoz, Corvia and Abbott, outside the submitted work. D.M. reports reports grants, personal fees and non-financial support from consulting honoraria, speaker fees and educational grants from Abbott, Novartis, Roche diagnostics, Bayer, Pfizer, Boehringer Ingelheim, Amgen, Sanofi, Krka, Novo Nordisk and Berlin Chemie Menarini. M.C. reports grants, personal fees and non-financial support from Novartis, Abbott, GE Healthcare, Corvia, Pfizer, Bayer, Boehringer-Ingelheim, AstraZeneca, Sanofi, Teva Pharmaceutical Industries, Orion Pharma and Medtronic, outside the submitted work. P.G.C., H.D., I.I., E.G., M.Z., F.C., M.S., B.B. and A.B. report no potential conflict of interest.
